BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21534134)

  • 1. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 2. Social contexts influence ethical considerations of research.
    Gordon JB; Levine RJ; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):24-30. PubMed ID: 21534146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social contexts, social media, and human subjects research.
    Foulkes M
    Am J Bioeth; 2011 May; 11(5):35-6. PubMed ID: 21534149
    [No Abstract]   [Full Text] [Related]  

  • 4. Research impacting social contexts: the moral import of community-based participatory research.
    Munoz R; Fox MD
    Am J Bioeth; 2011 May; 11(5):37-8. PubMed ID: 21534150
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for topically focused efforts to deal with the long-term social implications of research.
    Benya F
    Am J Bioeth; 2011 May; 11(5):19-20. PubMed ID: 21534143
    [No Abstract]   [Full Text] [Related]  

  • 7. IRBs and the long-term social implications of research.
    de Melo-Martin I
    Am J Bioeth; 2011 May; 11(5):22-3. PubMed ID: 21534145
    [No Abstract]   [Full Text] [Related]  

  • 8. Civic trust, scientific objectivity, and the publicity condition.
    Potter NN
    Am J Bioeth; 2010 Aug; 10(8):57-8. PubMed ID: 20694911
    [No Abstract]   [Full Text] [Related]  

  • 9. A plea for pragmatism in clinical research ethics.
    Brendel DH; Miller FG
    Am J Bioeth; 2008 Apr; 8(4):24-31. PubMed ID: 18576248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing a disconnect?
    White GB
    Am J Bioeth; 2011 May; 11(5):20-2. PubMed ID: 21534144
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethics. Human health research ethics.
    Silbergeld E; Lerman S; Hushka L
    Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical human-research protections: not universal and not uniform.
    Fleming DA; Reynolds D
    Am J Bioeth; 2008 Nov; 8(11):21-2. PubMed ID: 19061102
    [No Abstract]   [Full Text] [Related]  

  • 13. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to open peer commentaries on "research exceptionalism".
    Hunter D; Wilson J
    Am J Bioeth; 2010 Aug; 10(8):W4-6. PubMed ID: 20694896
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the case for the regulation of research.
    Wilkinson T
    Am J Bioeth; 2010 Aug; 10(8):63-5. PubMed ID: 20694915
    [No Abstract]   [Full Text] [Related]  

  • 16. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatism as a complementary approach to legislation: closing regulatory gaps in human subject research.
    Vernillo A
    Am J Bioeth; 2008 Nov; 8(11):15-7. PubMed ID: 19061099
    [No Abstract]   [Full Text] [Related]  

  • 18. Extend the reach of institutional review boards first, then strengthen their depth.
    Spike J
    Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of controversial research in the IRB's risk/benefit analysis.
    Lunstroth J
    Am J Bioeth; 2011 May; 11(5):14-6. PubMed ID: 21534141
    [No Abstract]   [Full Text] [Related]  

  • 20. A taxonomy of value in clinical research.
    Casarett DJ; Karlawish JH; Moreno JD
    IRB; 2002; 24(6):1-6. PubMed ID: 12683394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.